This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Stahl N, Ungerstedt U, Nordstrom CH (2001) Brain energy metabolism during controlled Reduction of cerebral perfusion pressure in severe head injuries. Intensive Care Med 27:1215–1223
Joukhadar C, Stass H, Muller-Zellenberg U et al (2003) Penetration of moxifloxacin into healthy and inflamed subcutaneous adipose tissues in humans. Antimicrob Agents Chemother 47:3099–3103
Muller M, Stass H, Brunner M et al (1999) Penetration of moxifloxacin into peripheral compartments in humans. Antimicrob Agents Chemother 43:2345–2349
Bellmann R, Kuchling G, Dehghanyar P et al (2004) Tissue pharmacokinetics of levofloxacin in human soft tissue infections. Br J Clin Pharmacol 57:563–568
Brunner M, Stabeta H, Moller JG et al (2002) Target site concentrations of ciprofloxacin after single intravenous and oral doses. Antimicrob Agents Chemother 46:3724–3730
Joukhadar C, Klein N, Frossard M et al (2001) Angioplasty increases target site concentrations of ciprofloxacin in patients with peripheral arterial occlusive disease. Clin Pharmacol Ther 70:532–539
Muller M, Brunner M, Hollenstein U et al (1999) Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients. Antimicrob Agents Chemother 43:2056–2058
Liu P, Muller M, Grant M et al (2002) Interstitial tissue concentrations of cefpodoxime. J Antimicrob Chemother 50Suppl:19–22
Huovinen P (1999) Antibiotic usage and the incidence of resistance. Clin Microbiol Infect 54:S12–S16
Joukhadar C, Frossard M, Mayer BX et al (2001) Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock. Crit Care Med 29:385–391
Brunner M, Pernerstorfer T, Mayer BX et al (2000) Surgery and intensive care procedures affect the target site distribution of piperacillin. Crit Care Med 28:1754–1759
Tegeder I, Schmidtko A, Brautigam L et al (2002) Tissue distribution of imipenem in critically ill patients. Clin Pharmacol Ther 71:325–333
Joukhadar C, Klein N, Mayer BX et al (2002) Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis. Crit Care Med 30:1478–1482
Joukhadar C, Klein N, Dittrich P et al (2003) Target site penetration of fosfomycin in critically ill patients. J Antimicrob Chemother 51:1247–1252
Zeitlinger MA, Dehghanyar P, Mayer BX et al (2003) Relevance of soft-tissue penetration by levofloxacin for target site bacterial killing in patients with sepsis. Antimicrob Agents Chemother 47:3548–3553
Delacher S, Derendorf H, Hollenstein U et al (2000) A combined in vivo pharmacokinetic-in vitro pharmacodynamic approach to simulate target site pharmacodynamics of antibiotics in humans. J Antimicrob Chemother 46:733–739
Zeitlinger MA, Marsik C, Georgopoulos A et al (2003) Target site bacterial killing of cefpirome and fosfomycin in critically ill patients. Int J Antimicrob Agents 21:562–567
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Italia
About this paper
Cite this paper
Kulemann, V., Joukhadar, C. (2005). The pharmacokinetics and pharmacodynamics of antimicrobial agents in intensive care unit patients as assessed by microdialysis. In: Gullo, A. (eds) Anaesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E.. Springer, Milano. https://doi.org/10.1007/88-470-0351-2_17
Download citation
DOI: https://doi.org/10.1007/88-470-0351-2_17
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0288-3
Online ISBN: 978-88-470-0351-4
eBook Packages: MedicineMedicine (R0)